tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O
Germany Market

OncoTherapy Science (30O) Income Statement

Compare
0 Followers

OncoTherapy Science Income Statement

Last quarter (Q3 2024), OncoTherapy Science's total revenue was ¥338.00M, an increase of 208.52% from the same quarter last year. In Q3, OncoTherapy Science's net income was ¥-172.00M. See OncoTherapy Science’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 750.05M¥ 610.12M¥ 1.13B¥ 1.15B¥ 332.48M
Gross Profit
¥ -12.76M¥ -177.72M¥ 41.69M¥ 113.91M¥ 19.54M
Operating Expenses
¥ 785.18M¥ 943.08M¥ 1.15B¥ 2.17B¥ 1.66B
Depreciation and Amortization
¥ 0.00¥ 2.00K¥ 16.00M¥ 16.54M¥ 49.01M
EBITDA
¥ -811.92M¥ -1.29B¥ -1.09B¥ -2.04B¥ -1.59B
Operating Income
¥ -797.94M¥ -1.12B¥ -1.11B¥ -2.05B¥ -1.64B
Other Income/Expenses
¥ -15.19M¥ -164.91M¥ -10.01M¥ -517.67M¥ 77.92M
Pretax Income
¥ -813.13M¥ -1.29B¥ -1.12B¥ -2.57B¥ -1.56B
Net Income
¥ -815.28M¥ -1.29B¥ -1.12B¥ -2.57B¥ -1.56B
Per Share Metrics
Basic EPS
¥ -3.12¥ -6.05¥ -5.81¥ -13.72¥ -8.86
Diluted EPS
¥ -3.12¥ -6.05¥ -5.81¥ -13.72¥ -8.86
Weighted Average Shares Outstanding
261.14M 212.78M 192.64M 187.47M 176.33M
Weighted Average Shares Outstanding (Diluted)
261.14M 212.78M 192.64M 187.47M 176.33M
Currency in JPY

OncoTherapy Science Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis